Related Experiment Videos
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
T Visakorpi1, O P Kallioniemi, A Heikkinen
1Department of Chemistry, Tampere University Hospital, Finland.
Journal of the National Cancer Institute
|June 3, 1992
Summary
High-level p53 protein accumulation in prostate cancer indicates aggressive disease. This finding is linked to higher tumor grade, DNA aneuploidy, and increased cell proliferation, predicting poorer outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- p53 gene mutations lead to altered p53 protein accumulation in various human cancers.
- This accumulation is a hallmark of several malignancies, suggesting a role in tumor development.
Purpose of the Study:
- To investigate the clinical significance of p53 protein accumulation in prostate carcinoma.
- To determine if p53 accumulation correlates with tumor characteristics and patient prognosis.
Main Methods:
- Immunohistochemical staining using a p53-specific antibody (CM-1) on 137 primary prostate carcinoma samples.
- Assessment of cell proliferation using DNA flow cytometry and PCNA (proliferative cell nuclear antigen) immunohistochemistry.
Main Results:
- High-level p53 accumulation was observed in 6% of tumors and was significantly associated with high histologic grade, DNA aneuploidy, and elevated cell proliferation rates (P < .001).
- High-level p53 accumulation predicted a shorter progression-free interval (P < .01) and poorer survival (P < .001), indicating a 12-fold increased risk of death.
- Low-level p53 accumulation did not show prognostic significance.
Conclusions:
- p53 protein accumulation confers a proliferative advantage to prostate carcinoma cells.
- This accumulation identifies a distinct subgroup of highly malignant prostate cancers with poor prognosis.